Avedro Announces FDA Priority Review Status! – Corneal Cross-linking!
This is huge news for the keratoconic community. The priority review status for the New Drug Application (NDA) places the application action date at March 15th, 2014.
Avedro Announces FDA Priority Review Status! – Corneal Cross-linking!
This is huge news for the keratoconic community. The priority review status for the New Drug Application (NDA) places the application action date at March 15th, 2014.
©2025. All Rights Reserved.
If you are using a screen reader and are having problems using this website, please call 201-692-9434. Accessibility || Website Disclaimer | Privacy Policy
